Loading provider…
Loading provider…
Infectious Disease Physician in Houston, TX
NPI: 1013097443Primary Practice Location
HARRIS HEALTH
1504 Taub Loop, Houston, TX
Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get MD Elizabeth's Phone NumberMobile
Get MD Elizabeth's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
FL State Medical License
2021
TX State Medical License
2004 - 2027
WA State Medical License
2023 - 2026
AL State Medical License
2023 - 2025
AZ State Medical License
2023 - 2025
GA State Medical License
2023 - 2025
LA State Medical License
2023 - 2025
MS State Medical License
2023 - 2025
OK State Medical License
2023 - 2025
TN State Medical License
2023 - 2025
NY State Medical License
2002 - 2005
UT State Medical License
1999 - 2004

American Board of Internal Medicine
Infectious Disease

American Board of Internal Medicine
Medical Oncology
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2002 - 2004
University of Utah Health
Residency • Internal Medicine
1998 - 2001
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 1998
Baylor College Of Medicine
bcm.edu
Fellowship • Infectious Disease
2004 - 2005
Risk factors for oropharynx cancer in a cohort of HIV-infected veterans
Authors: Thomas Giordano
Journal: Arch Intern Med
Self‐management intervention for head and neck cancer couples: Results of a randomized pilot trial
Authors: Timothy Wagner, Vlad Sandulache
Publication Date: 2019-04
Lead Sponsor: Andrew Dinardo
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Azacitidine Injection
Lead Sponsor: Baylor College of Medicine
Collaborators: University of California, San Francisco, Medical University of South Carolina, M.D. Anderson Cancer Center, The University of Texas Health Science Center, Houston, Icahn School of Medicine at Mount Sinai, William Marsh Rice University
Intervention / Treatment: DIAGNOSTIC_TEST: High resolution anoscopy, DRUG: Proflavine Hemisulfate, DIAGNOSTIC_TEST: mHRME (Mobile High resolution microendoscope)
Lead Sponsor: AIDS Malignancy Consortium
Collaborators: National Cancer Institute (NCI), University of California, Los Angeles, The Emmes Company, LLC, University of Arkansas, AIDS and Cancer Specimen Resource, Montefiore Medical Center
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Nelfinavir Mesylate